Communicating the Value of Field Medical to Internal Stakeholders
In this first podcast, the first of a two-part series, we will discuss communicating the value of Field Medical to internal stakeholders.
In this first podcast, the first of a two-part series, we will discuss communicating the value of Field Medical to internal stakeholders.
In this podcast, we explore best practices for gathering content (beyond simply creating it yourself!), and making content accessible in modern, personalized platforms.
Hosted by experienced medical communications experts and industry leaders, this webinar covers how a holistic approach towards a Publication Extender Strategy can elevate the scientific exchange between the industry and HCPs.
Pharmaceutical companies can make information easily accessible and easy to understand with publication extenders, as HCPs are in need of short form, bite-sized information to aid their medical decision making. However, in an age of information overload, a personalized, relevant approach is necessary to reach and engage them effectively.
Current practice is based on one-off, ad-hoc creation of publication extenders, and many important facets of effective communication strategies are often overlooked. The approach presented during this webinar emphasizes the importance of defining clear audience segments, using omnichannel methodology, and learning how to reach a wider audience through a variety of formats.
Participants in this webinar will learn about the benefits of a holistic Publication Extender Strategy and gain practical insights on how to implement one effectively.
Join us for this informative webinar to stay ahead of the curve in the fast-paced world of digital medical communications and learn how to leverage the power of the holistic Publication Extender Strategy to create compelling content and inform, educate, and engage HCPs more effectively.
At the end of the session, you will be able to:​
In this podcast, two data specialists discuss the ways in which Medical Affairs professionals can use this data to discover your next generation of researchers, those influencers whose voices are heard on Twitter, and how your KOLs are interacting with others online.
The growth of Real-World Evidence (RWE) from sources including patient registries, claims data, electronic medical records, digital health technologies and more has powered the ability of Medical Affairs to drive patient outcomes. Here, the MAPS Executive Consortium describes how.
MAPS is pleased to share our 2023 Medical Metrics Benchmarking Report, based on findings from 51 leading organizations representing the Pharmaceutical, Biotech, and Medical and Diagnostic Device sectors.
As evidence generation becomes more advanced and integrated into Medical Affairs strategic plans, there is a greater need to maximize its impact by leveraging emerging digital technologies to communicate complex clinical and nonclinical data.
In this episode, listeners will better understand what innovative content is in the context of Medical Information while setting expectations of HCPs in accessing innovative content.
MAPS announces the election of Dr. Danie du Plessis as Chair of the MAPS Board of Directors. Du Plessis is currently Executive Vice-President (EVP) & Head of Medical Affairs at Kyowa Kirin International and is a senior pharmaceutical executive with 30 years’ experience.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.